Elicio
Elicio is a Massachusetts-based biotechnology company that discovers and develops novel immunotherapies for the treatment of cancer.
Business Model:
Revenue: $3.1M
Employees: 11-50
Industries / Tags:
Detailed Elicio Information
Geographic Data
Address: 451 D Street
City: Boston
State: MA
Zip: 02210
Country: US
Financial Info
Stage:
seed
Raised Last:
$975k
Raised Total:$164M
Social
Metrics
4,681,937Website Global Rank
1,896Website Monthly Traffic
Twitter Followers
Description
Elicio is a Massachusetts-based biotechnology company that discovers and develops novel immunotherapies for the treatment of cancer.
Contact Phone:
+18572090050
Contact Email:
Elicio went public on the NASDAQ
Listed Exchange:
NASDAQ
Ticker Symbol:
ELTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Seed Round | $975k | 3/2020 | Venture Round | $8.4M | 1/2023 | Debt Financing | 1 | $10M |
Angion Angion |
5/2022 | Series C | $37M | 8/2012 | Venture Round | 1 | $3.3M |
Access BridgeGap Ventures Access BridgeGap Ventures |
11/2018 | Venture Round | - |
Thynk Capital, LLC. Thynk Capital, LLC. |
3/2019 | Venture Round | $30M | 11/2021 | Debt Financing | $14.5M | 2/2021 | Series B | - | 9/2022 | Grant | $2.8M |
Gastro-Intestinal Research Foundation |
10/2020 | Series B | 1 | - |
Trend Investment Group Trend Investment Group |
5/2022 | Equity | $22M | 7/2020 | Series B | $6.1M | 5/2016 | Venture Round | $750k | 10/2021 | Convertible Note | $14.5M | 8/2018 | Debt Financing | - | 2/2021 | Series B | $73M | 10/2019 | Series B | 3 | $33M |
Livzon Pharmaceutical Group Clal Biotechnology Industries EFung Capital Clal Biotechnology Industries EFung Capital Livzon Pharmaceutical Group Livzon Pharmaceutical Group Clal Biotechnology Industries EFung Capital Clal Biotechnology Industries EFung Capital Livzon Pharmaceutical Group |
11/2022 | Grant | $0 |
Gastro-Intestinal Research Foundation Gastro-Intestinal Research Foundation |
2/2021 | Series B | - | 10/2020 | Series B | 1 | - |
Trend Investment Group Trend Investment Group |
11/2018 | Venture Round | 1 | - |
Thynk Capital, LLC. Thynk Capital, LLC. |
8/2018 | Debt Financing | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
